Aptevo Therapeutics

APVO

APVO Aptevo Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    APVO Chart
    See on advanced chart >

    About

    Aptevo Therapeutics Inc. was incorporated in the state of Delaware in February 2016. The company is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapy candidates for the treatment of different forms of...
    • Highlight
      A biotechnology company developing novel immunotherapies for cancer and autoimmune diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      08/01/2016
    • Established Date
      Invalid Date
    • Full-time Employees
      40
    • Address
      2401 4th Avenue Suite 1050 Seattle Washington 98121
    • Tel
      1-206-8380500
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock